1
VERTEX PHARMACEUTICALS INC
COM
VRTX
VRTX
950,000
$191.5m5.18%
5.18%
Added Shares held: Q3 2020 0, Q4 2020 147.3k, Q1 2021 310.9k, Q2 2021 950.0k
+639.1k
+639,100
205.6%
2
ABBVIE INC
COM
ABBV
ABBV
1,484,400
$167.2m4.52%
4.52%
Reduced Shares held: Q3 2020 1.5m, Q4 2020 1.4m, Q1 2021 2.1m, Q2 2021 1.5m
-592.8k
-592,800
-28.5%
3
ARVINAS INC
COM
ARVN
ARVN
1,854,000
$142.8m3.86%
3.86%
Added Shares held: Q3 2020 1.3m, Q4 2020 1.8m, Q1 2021 1.8m, Q2 2021 1.9m
+93.7k
+93,700
5.3%
4
ELI LILLY & CO
COM
LLY
LLY
565,500
$129.8m3.51%
3.51%
New Shares held: Q3 2020 0, Q4 2020 810.5k, Q1 2021 0, Q2 2021 565.5k
5
MARAVAI LIFESCIENCES HLDGS I
COM CL A
MRVI
MRVI
2,963,545
$123.7m3.34%
3.34%
Added Shares held: Q3 2020 0, Q4 2020 3.4m, Q1 2021 2.8m, Q2 2021 3.0m
+202.0k
+202,000
7.3%
6
MIRATI THERAPEUTICS INC
COM
MRTX
MRTX
753,000
$121.6m3.29%
3.29%
Added Shares held: Q3 2020 275.0k, Q4 2020 380.0k, Q1 2021 475.7k, Q2 2021 753.0k
+277.3k
+277,300
58.3%
7
ZENTALIS PHARMACEUTICALS INC
COM
ZNTL
ZNTL
2,160,000
$114.9m3.11%
3.11%
Added Shares held: Q3 2020 904.1k, Q4 2020 1.1m, Q1 2021 1.3m, Q2 2021 2.2m
+896.7k
+896,700
71.0%
8
AVANTOR INC
COM
AVTR
AVTR
3,180,000
$112.9m3.05%
3.05%
Reduced Shares held: Q3 2020 4.6m, Q4 2020 6.6m, Q1 2021 5.0m, Q2 2021 3.2m
-1.8m
-1,805,100
-36.2%
9
SEAGEN INC
COM
SGEN
SGEN
640,000
$101.0m2.73%
2.73%
Added Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 577.9k, Q2 2021 640.0k
+62.1k
+62,100
10.8%
10
BIOHAVEN PHARMACTL HLDG CO L
COM
BHVN
BHVN
882,500
$85.7m2.32%
2.32%
Reduced Shares held: Q3 2020 1.3m, Q4 2020 491.8k, Q1 2021 1.0m, Q2 2021 882.5k
-167.3k
-167,300
-15.9%
11
HOLOGIC INC
COM
HOLX
HOLX
1,208,800
$80.7m2.18%
2.18%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.2m
12
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
4,615,000
$79.2m2.14%
2.14%
Added Shares held: Q3 2020 1.9m, Q4 2020 3.3m, Q1 2021 3.8m, Q2 2021 4.6m
+769.0k
+769,000
20.0%
13
ESSA PHARMA INC
COM NEW
EPI
EPI
2,750,000
$78.6m2.12%
2.12%
Reduced Shares held: Q3 2020 2.1m, Q4 2020 2.6m, Q1 2021 2.8m, Q2 2021 2.8m
-90.0k
-90,000
-3.2%
14
EXACT SCIENCES CORP
COM
EXAS
EXAS
590,000
$73.3m1.98%
1.98%
Reduced Shares held: Q3 2020 0, Q4 2020 247.0k, Q1 2021 598.0k, Q2 2021 590.0k
-8.0k
-8,000
-1.3%
15
MEDTRONIC PLC
SHS
MDT
MDT
535,000
$66.4m1.79%
1.79%
Reduced Shares held: Q3 2020 181.0k, Q4 2020 301.0k, Q1 2021 1.0m, Q2 2021 535.0k
-489.2k
-489,200
-47.8%
16
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
681,000
$66.3m1.79%
1.79%
Added Shares held: Q3 2020 0, Q4 2020 300.0k, Q1 2021 521.4k, Q2 2021 681.0k
+159.6k
+159,600
30.6%
17
NUVATION BIO INC
COM CL A
NUVB
NUVB
6,966,376
$64.9m1.75%
1.75%
Reduced Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 7.5m, Q2 2021 7.0m
-555.6k
-555,565
-7.4%
18
ARENA PHARMACEUTICALS INC
COM NEW
ARNA
ARNA
943,000
$64.3m1.74%
1.74%
Added Shares held: Q3 2020 0, Q4 2020 621.0k, Q1 2021 898.5k, Q2 2021 943.0k
+44.5k
+44,450
5.0%
19
BIOGEN INC
COM
BIIB
BIIB
183,900
$63.7m1.72%
1.72%
New Shares held: Q3 2020 315.1k, Q4 2020 0, Q1 2021 0, Q2 2021 183.9k
20
NEOGENOMICS INC
COM NEW
NEO
NEO
1,367,000
$61.7m1.67%
1.67%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.4m
21
INTELLIA THERAPEUTICS INC
COM
NTLA
NTLA
380,000
$61.5m1.66%
1.66%
New Shares held: Q3 2020 0, Q4 2020 303.0k, Q1 2021 0, Q2 2021 380.0k
22
I MAB
SPONSORED ADS
NBP
NBP
729,000
$61.2m1.65%
1.65%
Reduced Shares held: Q3 2020 1.3m, Q4 2020 1.6m, Q1 2021 1.3m, Q2 2021 729.0k
-600.0k
-600,000
-45.1%
23
CATALENT INC
COM
CTLT
CTLT
540,000
$58.4m1.58%
1.58%
Reduced Shares held: Q3 2020 318.1k, Q4 2020 337.0k, Q1 2021 560.0k, Q2 2021 540.0k
-20.0k
-20,000
-3.6%
24
SHATTUCK LABS INC
COM
STTK
STTK
1,940,200
$56.2m1.52%
1.52%
Added Shares held: Q3 2020 0, Q4 2020 938.8k, Q1 2021 1.3m, Q2 2021 1.9m
+609.8k
+609,815
45.8%
25
CENTENE CORP DEL
COM
CNC
CNC
751,200
$54.8m1.48%
1.48%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 751.2k
26
HORIZON THERAPEUTICS PUB L
SHS
HZNP
HZNP
568,000
$53.2m1.44%
1.44%
Reduced Shares held: Q3 2020 930.2k, Q4 2020 1.2m, Q1 2021 581.0k, Q2 2021 568.0k
-13.0k
-13,000
-2.2%
27
BLUEPRINT MEDICINES CORP
COM
BPMC
BPMC
563,200
$49.5m1.34%
1.34%
Added Shares held: Q3 2020 0, Q4 2020 240.0k, Q1 2021 546.0k, Q2 2021 563.2k
+17.2k
+17,200
3.1%
28
NATERA INC
COM
NTRA
NTRA
436,000
$49.5m1.34%
1.34%
Added Shares held: Q3 2020 503.4k, Q4 2020 479.8k, Q1 2021 395.6k, Q2 2021 436.0k
+40.4k
+40,400
10.2%
29
SOTERA HEALTH CO
COM
SHC
SHC
1,910,000
$46.3m1.25%
1.25%
Added Shares held: Q3 2020 0, Q4 2020 700.0k, Q1 2021 1.2m, Q2 2021 1.9m
+749.0k
+749,000
64.5%
30
ACCELERON PHARMA INC
COM
XLRN
XLRN
358,500
$45.0m1.22%
1.22%
Added Shares held: Q3 2020 0, Q4 2020 299.0k, Q1 2021 322.8k, Q2 2021 358.5k
+35.7k
+35,700
11.1%
31
IDEAYA BIOSCIENCES INC
COM
IDYA
IDYA
2,070,000
$43.4m1.17%
1.17%
Added Shares held: Q3 2020 1.1m, Q4 2020 0, Q1 2021 1.5m, Q2 2021 2.1m
+598.0k
+598,000
40.6%
32
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
236,400
$42.4m1.15%
1.15%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 236.4k
33
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
673,400
$41.0m1.11%
1.11%
Reduced Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 815.1k, Q2 2021 673.4k
-141.7k
-141,700
-17.4%
34
ALPHATEC HLDGS INC
COM NEW
ATEC
ATEC
2,621,000
$40.2m1.09%
1.09%
Added Shares held: Q3 2020 0, Q4 2020 1.9m, Q1 2021 2.3m, Q2 2021 2.6m
+287.0k
+287,000
12.3%
35
TRILLIUM THERAPEUTICS INC
COM NEW
TR
TR
4,105,000
$39.8m1.08%
1.08%
Added Shares held: Q3 2020 1.7m, Q4 2020 3.2m, Q1 2021 4.0m, Q2 2021 4.1m
+90.0k
+90,000
2.2%
36
CYTEIR THERAPEUTICS INC
COM
COM
1,808,394
$38.7m1.05%
1.05%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.8m
37
COMPASS PATHWAYS PLC
SPONSORED ADS
CMPS
CMPS
1,000,000
$38.1m1.03%
1.03%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.0m
38
CARDINAL HEALTH INC
COM
CAH
CAH
654,200
$37.3m1.01%
1.01%
Reduced Shares held: Q3 2020 0, Q4 2020 808.0k, Q1 2021 1.5m, Q2 2021 654.2k
-808.8k
-808,800
-55.3%
39
KADMON HLDGS INC
COM
KDMN
KDMN
9,294,600
$36.0m0.97%
0.97%
Reduced Shares held: Q3 2020 9.0m, Q4 2020 9.6m, Q1 2021 9.5m, Q2 2021 9.3m
-249.6k
-249,600
-2.6%
40
DYNAVAX TECHNOLOGIES CORP
COM NEW
DVAX
DVAX
3,400,000
$33.5m0.91%
0.91%
Reduced Shares held: Q3 2020 2.0m, Q4 2020 4.0m, Q1 2021 3.5m, Q2 2021 3.4m
-100.0k
-100,000
-2.9%
41
ALNYLAM PHARMACEUTICALS INC
COM
ALNY
ALNY
195,000
$33.1m0.89%
0.89%
Reduced Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 428.0k, Q2 2021 195.0k
-233.0k
-232,969
-54.4%
42
INSMED INC
COM PAR $.01
INSM
INSM
1,150,050
$32.7m0.88%
0.88%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.2m
43
SEASPINE HLDGS CORP
COM
SPNE
SPNE
1,524,998
$31.3m0.85%
0.85%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.5m
44
LIFESTANCE HEALTH GROUP INC
COM
LFST
LFST
1,100,000
$30.6m0.83%
0.83%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.1m
45
CENTURY THERAPEUTICS INC
COM
IPSC
IPSC
1,003,522
$29.4m0.80%
0.80%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.0m
46
LEGEND BIOTECH CORP
SPONSORED ADS
LEGN
LEGN
625,000
$25.7m0.69%
0.69%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 625.0k
47
IMMUNOCORE HLDGS PLC
ADS
IMCR
IMCR
601,000
$23.5m0.63%
0.63%
Added Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 550.0k, Q2 2021 601.0k
+51.0k
+51,000
9.3%
48
ADICET BIO INC
COM
COM
2,250,500
$23.2m0.63%
0.63%
Added Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 2.2m, Q2 2021 2.3m
+20.5k
+20,500
0.9%
49
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
940,000
$22.9m0.62%
0.62%
New Shares held: Q3 2020 0, Q4 2020 527.6k, Q1 2021 0, Q2 2021 940.0k
50
GRAPHITE BIO INC
COM
GRPH
GRPH
735,500
$22.6m0.61%
0.61%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 735.5k
51
HARPOON THERAPEUTICS INC
COM
COM
1,500,000
$20.8m0.56%
0.56%
Added Shares held: Q3 2020 1.2m, Q4 2020 785.0k, Q1 2021 1.4m, Q2 2021 1.5m
+92.0k
+92,000
6.5%
52
UIPATH INC
CL A
PATH
PATH
300,000
$20.4m0.55%
0.55%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 300.0k
53
GRITSTONE BIO INC
COM
GRTS
GRTS
2,122,064
$19.4m0.52%
0.52%
Unchanged Shares held: Q3 2020 0, Q4 2020 2.1m, Q1 2021 2.1m, Q2 2021 2.1m
54
SI-BONE INC
COM
SIBN
SIBN
575,000
$18.1m0.49%
0.49%
Reduced Shares held: Q3 2020 0, Q4 2020 639.9k, Q1 2021 577.6k, Q2 2021 575.0k
-2.6k
-2,570
-0.4%
55
ZAI LAB LTD
ADR
ZLAB
ZLAB
100,000
$17.7m0.48%
0.48%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
56
ORCHARD THERAPEUTICS PLC
ADS
ORTX
ORTX
3,781,798
$16.6m0.45%
0.45%
Reduced Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 4.3m, Q2 2021 3.8m
-536.0k
-536,002
-12.4%
57
ALDEYRA THERAPEUTICS INC
COM
ALDX
ALDX
1,450,000
$16.4m0.44%
0.44%
Reduced Shares held: Q3 2020 1.4m, Q4 2020 1.4m, Q1 2021 2.6m, Q2 2021 1.4m
-1.1m
-1,102,000
-43.2%
58
PHASEBIO PHARMACEUTICALS INC
COM
PHAS
PHAS
4,315,000
$16.1m0.43%
0.43%
Added Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 4.3m, Q2 2021 4.3m
+30.0k
+30,000
0.7%
59
SYNEOS HEALTH INC
CL A
INCR
INCR
175,000
$15.7m0.42%
0.42%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 175.0k
60
SANA BIOTECHNOLOGY INC
COM
SANA
SANA
778,597
$15.3m0.41%
0.41%
Added Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 732.3k, Q2 2021 778.6k
+46.3k
+46,276
6.3%
61
SCYNEXIS INC
COM NEW
COM NEW
2,060,000
$15.2m0.41%
0.41%
Added Shares held: Q3 2020 0, Q4 2020 1.3m, Q1 2021 1.3m, Q2 2021 2.1m
+796.2k
+796,231
63.0%
62
ALPINE IMMUNE SCIENCES INC
COM
NVLS
NVLS
1,495,000
$13.5m0.36%
0.36%
Reduced Shares held: Q3 2020 810.0k, Q4 2020 1.2m, Q1 2021 1.5m, Q2 2021 1.5m
-16.0k
-16,000
-1.1%
63
BELLUS HEALTH INC NEW
COM NEW
BLU
BLU
4,250,000
$13.2m0.36%
0.36%
Reduced Shares held: Q3 2020 0, Q4 2020 5.7m, Q1 2021 6.8m, Q2 2021 4.2m
-2.5m
-2,547,400
-37.5%
64
AC IMMUNE SA
SHS
ACIU
ACIU
1,584,000
$12.6m0.34%
0.34%
New Shares held: Q3 2020 1.6m, Q4 2020 0, Q1 2021 0, Q2 2021 1.6m
65
GH RESEARCH PLC
ORDINARY SHARES
GHRS
GHRS
560,000
$12.2m0.33%
0.33%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 560.0k
66
NAUTILUS BIOTECHNOLOGY INC
COM
NAUT
NAUT
1,125,000
$11.4m0.31%
0.31%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.1m
67
WEREWOLF THERAPEUTICS INC
COM
HOWL
HOWL
650,265
$11.3m0.31%
0.31%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 650.3k
68
ZETA GLOBAL HOLDINGS CORP
CL A
ZETA
ZETA
1,300,000
$10.9m0.30%
0.30%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.3m
69
CAREMAX INC
COM CL A
COM CL A
817,402
$10.5m0.28%
0.28%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 817.4k
70
PROTHENA CORP PLC
SHS
PRTA
PRTA
182,000
$9.4m0.25%
0.25%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 182.0k
71
CARDIFF ONCOLOGY INC
COM
CRDF
CRDF
1,395,000
$9.3m0.25%
0.25%
Reduced Shares held: Q3 2020 0, Q4 2020 1.6m, Q1 2021 2.4m, Q2 2021 1.4m
-1.1m
-1,052,700
-43.0%
72
MONDAY COM LTD
SHS
MNDY
MNDY
40,000
$8.9m0.24%
0.24%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 40.0k
73
IVERIC BIO INC
COM
OPHT
OPHT
1,400,010
$8.8m0.24%
0.24%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.4m
74
DOXIMITY INC
CL A
DOCS
DOCS
150,000
$8.7m0.24%
0.24%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
75
ARROWHEAD PHARMACEUTICALS IN
COM
ARWR
ARWR
104,000
$8.6m0.23%
0.23%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 104.0k
76
SENTINELONE INC
CL A
S
S
200,000
$8.5m0.23%
0.23%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 200.0k
77
ESPERION THERAPEUTICS INC NE
COM
ESPR
ESPR
400,000
$8.5m0.23%
0.23%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 400.0k
78
ONCOSEC MED INC
COM
COM
2,800,000
$7.9m0.21%
0.21%
Reduced Shares held: Q3 2020 0, Q4 2020 2.0m, Q1 2021 3.5m, Q2 2021 2.8m
-670.0k
-670,000
-19.3%
79
INSTIL BIO INC
COM
COM
400,000
$7.7m0.21%
0.21%
Unchanged Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 400.0k, Q2 2021 400.0k
80
VIR BIOTECHNOLOGY INC
COM
VIR
VIR
162,000
$7.7m0.21%
0.21%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 162.0k
81
PHARVARIS N V
COM
PHVS
PHVS
400,000
$7.5m0.20%
0.20%
Unchanged Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 400.0k, Q2 2021 400.0k
82
CM LIFE SCIENCES INC
COM CL A
COM CL A
525,000
$7.4m0.20%
0.20%
Reduced Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 550.0k, Q2 2021 525.0k
-25.0k
-25,000
-4.5%
83
MONTE ROSA THERAPEUTICS INC
COM
GLUE
GLUE
300,000
$6.8m0.18%
0.18%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 300.0k
84
DENALI THERAPEUTICS INC
COM
DNLI
DNLI
86,100
$6.8m0.18%
0.18%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 86.1k
85
ATAI LIFE SCIENCES NV
SHS
ATAI
ATAI
350,987
$6.5m0.18%
0.18%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 351.0k
86
TALARIS THERAPEUTICS INC
COM
COM
436,363
$6.4m0.17%
0.17%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 436.4k
87
ARYA SCIENCES ACQU CORP IV
CL A
CL A
500,000
$5.4m0.14%
0.14%
Unchanged Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 500.0k, Q2 2021 500.0k
88
BCLS ACQUISITION CORP
COM CL A
COM CL A
500,000
$5.3m0.14%
0.14%
Unchanged Shares held: Q3 2020 0, Q4 2020 500.0k, Q1 2021 500.0k, Q2 2021 500.0k
89
MEDICUS SCIENCES ACQUISITION
CL A SHS
CL A SHS
520,000
$5.0m0.14%
0.14%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 520.0k
90
FIGS INC
CL A
FIGS
FIGS
100,000
$5.0m0.14%
0.14%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
91
PANACEA ACQUISITION CORP II
CL A SHS
CL A SHS
500,000
$5.0m0.14%
0.14%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 500.0k
92
DYNAMICS SPECIAL PURPOSE COR
CLASS A COM
CLASS A COM
500,000
$5.0m0.13%
0.13%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 500.0k
93
HEALTHCOR CATALIO ACQU CORP
CL A SHS
HYPR
HYPR
500,000
$4.9m0.13%
0.13%
Unchanged Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 500.0k, Q2 2021 500.0k
94
CELCUITY INC
COM
CELC
CELC
200,000
$4.8m0.13%
0.13%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 200.0k
95
CONFLUENT INC
CLASS A COM
CFLT
CFLT
100,000
$4.8m0.13%
0.13%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
96
CM LIFE SCIENCES II INC
UNIT 02/25/2028
UNIT 02/25/2028
330,000
$4.4m0.12%
0.12%
Reduced Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 336.7k, Q2 2021 330.0k
-6.7k
-6,700
-2.0%
97
WALKME LTD
ORD SHS
ORD SHS
150,000
$4.4m0.12%
0.12%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
98
HELIX ACQUISITION CORP
COM CL A
MLTX
MLTX
400,000
$4.1m0.11%
0.11%
Unchanged Shares held: Q3 2020 0, Q4 2020 400.0k, Q1 2021 400.0k, Q2 2021 400.0k
99
HEALTH SCIENCES ACQ CORP 2
ORD SHS
OBIO
OBIO
400,000
$4.1m0.11%
0.11%
Unchanged Shares held: Q3 2020 400.0k, Q4 2020 400.0k, Q1 2021 400.0k, Q2 2021 400.0k
100
LIFESCI ACQUISITION II CORP
COM
COM
400,000
$4.0m0.11%
0.11%
Unchanged Shares held: Q3 2020 0, Q4 2020 400.0k, Q1 2021 400.0k, Q2 2021 400.0k